On this page
FSSAI suspends Flipkart seller Shreyash Retail's licence, serves notices on Flipkart, Amazon, Netmeds over Celevida ads
FSSAI suspended Shreyash Retail's licence after over 130 consumer complaints about expired food sold via Flipkart, and on Thursday issued notices to Dr Reddy's, Nestle Health Science, Flipkart, Amazon and Netmeds over misleading Celevida GLP+ advertising.
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
Channel facts
Figures from Business Standard,
| Complaints specifically on expired or rotten food: | 70 |
|---|---|
| Term barred from food labels and promotions: | 100% |
| Flagged claim: | Contains 100% RDA BCAA |
What it means for online and offline
If you sell food or supplements on marketplaces, audit seller licences, expiry and shelf-life controls, and nutrition claims on listings now, because FSSAI suspended Shreyash Retail's licence after 130+ complaints (70 on expired or rotten food) and sent notices to Flipkart, Amazon and Netmeds as well as the brand owners.
Signals to track
- An FSSAI follow-up order, penalty or hearing notice against any of the five noticed companies
- Celevida GLP+ listing or ad copy changing on Flipkart, Amazon or Netmeds
- New licence suspensions or notices against other food sellers on marketplaces
- A Flipkart statement or policy change on seller onboarding and food-licence verification
- A court filing or public appeal by Shreyash Retail against the suspension
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- Flipkart is likely to delist or restrict Shreyash Retail's food listings and publicly stress its seller-compliance checks, since most of the expired or rotten food complaints trace to its platform.
- Dr Reddy's and Nestle Health Science are likely to file replies defending Celevida GLP+ and quietly revise packaging or ad copy, with the 'Contains 100% RDA BCAA' line the most likely to go.
- Amazon and Netmeds are likely to pull or edit Celevida GLP+ listing content and argue they carried brand-supplied claims.
- FSSAI may widen its review to other nutrition and supplement listings on e-commerce platforms, using the Celevida notices as its template.
- Shreyash Retail may appeal or seek a hearing on the licence suspension rather than accept it.
The source
Published
First seen